Founder · Operator · Investor · Host
Building companies in regulated industries. Hosting conversations with founders, operators, and domain owners who are building without shortcuts — across healthcare, infrastructure, capital, and systems that actually matter.
From Mechanical Engineering to regulated pharmaceutical distribution — building in one of the hardest industries in entrepreneurship.
Establishing UK pharmaceutical distribution operations under MHRA and EU-GMP compliance. Building supplier networks across Europe. Navigating regulatory complexity in parallel import and generic medicine distribution. MHRA licensing in process. Operating across UK, Germany, Poland, Romania, Colombia, UAE.
Made the uncommon decision to enter regulated pharmaceutical distribution. No background in pharma. No healthcare network. No funding. Just deep research, cold outreach, and operator discipline. Began studying MHRA/EU-GMP frameworks, parallel import regulations, and cross-border pharmaceutical supply chains.
Worked at Swiggy during early growth phase. Learned how high-growth startups scale operations. Saw hypergrowth from the inside. Realized the path wasn't mine. Left to build in regulated industries.
Studied Mechanical Engineering. Learned systems thinking and analytical frameworks. Realized interest in building businesses rather than machines. Developed technical discipline that would later apply to regulated industries.
Born and raised in India. Educated in Vadodara and Porbandar. Early education at St. Mary's School, Don Bosco High School, and Zenith High School. The foundation that made everything else possible.
Long-form conversations with founders, operators, and domain experts building real companies — often in regulated, capital-intensive, or unglamorous industries.
This is not advice. This is not motivation. This is documentation.
Starting a regulated healthcare company is not glamorous. This is a chronicle of what actually happens — the failures, the bureaucracy, the breakthroughs that feel small but matter. Why I started this podcast, who it's for, and what to expect.
Listen Now →A detailed walkthrough of the UK pharmaceutical licensing application process. The documentation requirements, the waiting periods, the unexpected obstacles.
Listen Now →How to build a supplier database from scratch. Cold outreach strategies, building trust in a relationship-driven industry.
Listen Now →Subscribe: Apple Podcasts · Spotify · RSS Feed
Watch full conversations and episodes on YouTube
Be a GuestBuilding and investing in companies across regulated industries, healthcare infrastructure, and operator-led businesses.
Pharmaceutical distribution company focused on parallel imports and generic medicines across UK and European markets. Operating under MHRA and EU-GMP compliance standards.
Founder & CEO
Visit Website →Investing in category-defining healthcare ventures, regulated industry operators, and infrastructure-focused businesses building real-world value.
Investor & Advisor
Get in Touch →Deep-dive reports on pharmaceutical distribution, parallel import regulations, and generic medicine markets.
Coming Soon →Practical guides and frameworks for building in regulated industries, navigating compliance, and scaling operations.
Coming Soon →Speaking engagements on entrepreneurship in regulated markets, operator-led growth, and building outside Silicon Valley.
Learn More →Available for speaking engagements on entrepreneurship in regulated industries, operator-led growth, and building companies outside traditional startup ecosystems.
Navigating pharmaceutical regulation, MHRA/EU-GMP compliance, and the reality of building where mistakes have consequences.
Scaling businesses without venture capital, building real-world infrastructure, and the discipline of operator-first companies.
The economics of pharmaceutical distribution, cross-border supply chains, and reducing healthcare system costs.
Building from India, operating globally, and creating companies in capital-intensive, unglamorous industries.
Event schedule and speaking history will be updated here as engagements are confirmed.
Press features, milestones, and updates from building in regulated industries.
Announcing the official launch of NovaPharm Healthcare Ltd., focused on pharmaceutical distribution through parallel import and generic medicine channels across UK and European markets. MHRA licensing process underway.
Read More →Announcing Building from Zero — a long-form conversation series with founders, operators, and domain experts building real companies in regulated, capital-intensive industries. First three episodes now live.
Listen Now →Why choose pharmaceutical distribution — one of the hardest paths in entrepreneurship. Published essay exploring regulatory complexity, capital requirements, and the decision to build where barriers to entry are deliberately high.
Read Essay →For press inquiries: Contact
Long-form thinking on building companies, navigating regulated industries, and the reality of entrepreneurship outside Silicon Valley.
A data-driven framework for winning when structural disadvantages tilt the odds against you—covering asymmetric competition, discipline under pressure, and delayed recognition.
Read Essay →The term "parallel import" sounds technical and obscure. In reality, it's a mechanism that can save healthcare systems millions while maintaining the exact same drug quality and safety standards.
Read Essay →Most founders choose software because it's fast, scalable, and cheap to test. I chose pharmaceutical distribution — an industry where regulatory approval takes months, where mistakes can shut you down, and where the barriers to entry are deliberately high.
Read Essay →I spent a year at Swiggy during a period of explosive growth. Then I walked away from tech entirely to build a pharmaceutical distribution company in an industry I knew nothing about.
Read Essay →For speaking engagements, podcast guest appearances, press inquiries, partnerships, or professional opportunities.
Available for talks on entrepreneurship in regulated industries, operator-led growth, pharmaceutical distribution, and building outside Silicon Valley.
Open to long-form conversations with founders, operators, and domain experts building real companies in regulated or capital-intensive industries.
For media inquiries, interview requests, or press-related questions about NovaPharm Healthcare or building in regulated industries.
Pharmaceutical manufacturers, authorized distributors, or healthcare organizations interested in supply chain opportunities and parallel import collaborations.
Most reliable way to reach:
LinkedIn Profile